QS Investors’s Apyx Medical APYX Stock Holding History

QS Investors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$557K	Hold	54,000	–	–	0.01%	696
2021 Q1	$522K	Sell	54,000 -500	-0.9%	-$5K	0.01%	783
2020 Q4	$392K	Hold	54,500	–	–	﹤0.01%	892
2020 Q3	$257K	Sell	54,500 -179,000	-77%	-$886K	﹤0.01%	980
2020 Q2	$1.3M	Hold	233,500	–	–	0.02%	647
2020 Q1	$839K	Hold	233,500	–	–	0.01%	714
2019 Q4	$1.99M	Sell	233,500 -5,400	-2%	-$39K	0.02%	591
2019 Q3	$1.62M	Hold	238,900	–	–	0.02%	635
2019 Q2	$1.61M	Buy	238,900 +29,000	+14%	+$158K	0.02%	660
2019 Q1	$1.32M	Buy	+209,900	New	+$1.62M	0.01%	738

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QS Investors's APYX Position: Q2 2021 in Review

QS Investors held its Apyx Medical (APYX) position steady in Q2 2021 at 54,000 shares worth $557K. The position accounts for 0.01% of the portfolio, ranked #696.

QS Investors first reported a position in APYX in Q1 2019 and has held it in 10 quarters since. The position peaked at $1.99M in Q4 2019. 72 funds tracked by Wall St. Rank hold APYX as of Q2 2021.

QS Investors held 54,000 shares of Apyx Medical worth $557K as of Q2 2021.
QS Investors left its Apyx Medical share count unchanged in Q2 2021.
Apyx Medical made up 0.01% of QS Investors's portfolio in Q2 2021, its #696 holding.
QS Investors first reported a position in Apyx Medical in Q1 2019 and has held it in 10 quarters since.
QS Investors's Apyx Medical position peaked at $1.99M in Q4 2019.
72 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.